MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Serotonin Transporter Dynamics in Multiple System Atrophy: Insights from 123I-FP-CIT SPECT Imaging

R. Nagao, H. Watanabe (Toyoake, Japan)

Meeting: 2024 International Congress

Abstract Number: 6

Keywords: Multiple system atrophy(MSA): Clinical features, Multiple system atrophy(MSA): Pathophysiology, Single-photon emission computed tomography(SPECT)

Category: Parkinsonism, Atypical: MSA

Objective: We aimed to visualize a serotonin transporter (SERT) based on 123I-FP-CIT SPECT, and assessing the binding distribution characteristics of the brainstems between patients with multiple system atrophy (MSA) and controls and elucidate the correlations between the specific binding ratios (SBRs) of SERT and clinical indices in MSA patients.

Background: Previous studies have shown that serotonin neuronal loss in the brainstem of MSA is associated with autonomic failure and sudden death. Our findings demonstrate that serotonin dysfunction assessed by CSF 5-HIAA levels may be associated with MSA severity. However, the association between SERT and the pathophysiology of MSA is unclear.

Method: We enrolled 17 controls and 28 patients diagnosed with MSA according to the MDS MSA criteria. Among these patients, 25 had clinically established MSA, 3 had clinically probable MSA, 16 had MSA-P and 12 had MSA-C. There were 13 females and 15 males with a mean age of 62.9±8.8 years and a mean disease duration of 28.4±16.7 months. The mean CSF 5-HIAA levels was 9.3±5.0 ng/mL. We performed 123I-FP-CIT SPECT and 3D T1-weighted MRI to fix a reference lesion in the occipital lobe. The regions of interest were transferred to the SPECT images. The SBR distribution image was generated for the whole brainstem, midbrain and pons. We compared the total SBR of SERT at each site between MSA and controls and evaluated the correlation between SBR values and clinical scores in MSA. In addition, we also investigated the pathological examinations in other 10 MSA patients.

Results: The SERT-SBR was lower in the midbrain with MSA-P. Notably, the pons/midbrain ratio was significantly higher in both MSA-P and MSA-C patients (sensitivity 1.00; specificity 0.88; AUC 0.98) than in controls. Pathological studies also confirmed that SERT was increased in the pons and decreased in the midbrain. SBR did not correlate with CSF 5-HIAA levels, and there was no relationship in the principal component analysis. In MSA-P, SERT SBR in the midbrain and pons showed a negative correlation with UMSARS Part I and II.

Conclusion: An increased in SERT SBR in the pons and pons/midbrain ratios in MSA was observed, independent of clinical phenotype, disease duration, and CSF 5-HIAA levels. This feature was commonly detected in early and advanced stages.

To cite this abstract in AMA style:

R. Nagao, H. Watanabe. Serotonin Transporter Dynamics in Multiple System Atrophy: Insights from 123I-FP-CIT SPECT Imaging [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/serotonin-transporter-dynamics-in-multiple-system-atrophy-insights-from-123i-fp-cit-spect-imaging/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/serotonin-transporter-dynamics-in-multiple-system-atrophy-insights-from-123i-fp-cit-spect-imaging/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley